⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
APLS News
Apellis Pharmaceuticals, Inc. Common Stock
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
Tavo Biotherapeutics Announces $17 Million Series A Financing to Advance Novel Therapies in Glaucoma and Retinal Disease
prnewswire.com
APLS
Sobi to present new data on pegcetacoplan at ERA 2026
prnewswire.com
APLS
BIIB
EZLynx Receives Gold Stevie Award® in the 2026 American Business Awards®
globenewswire.com
APLS
Applied Systems Builds on AI Reconciliation Momentum with New Financial Operations Innovation
globenewswire.com
APLS
EMPAVELI Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
APLS
Form 8-K
sec.gov
APLS
BIIB
Biogen Completes Acquisition of Apellis Pharmaceuticals
globenewswire.com
BIIB
APLS
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
prnewswire.com
GILD
REGN
AMGN
JNJ
MRK
ALKS
APLS
EYPT
OCUL
VRTX
Appier Beats Q1 Revenue and Profit Targets with Agentic AI-driven Growth
prnewswire.com
APLS